Start: Of therapy with the angiotensin II antagonist losartan after immediate switch from pretreatment with an ACE inhibitor

British Journal of Clinical Pharmacology

Volumn 46, Issue 2, 1998, Pages 169-172

  Scholze, Juergen ^a,c   Stapff, Manfred ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MSD Sharp and Dohme GmbH   (Germany)

^c Humboldt University ^*  (Germany)

Author keywords

Ambulatory BP monitoring; Angiotensin; Antagonism; Captopril; Losartan; Switch

Indexed keywords

ANGIOTENSIN II ANTAGONIST; CAPTOPRIL; LOSARTAN;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CAPTOPRIL; DOUBLE-BLIND METHOD; FEMALE; HEADACHE; HUMANS; HYPERTENSION; LOSARTAN; MALE; RECEPTORS, ANGIOTENSIN;

EID: 0031855691     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00753.x     Document Type: Article

References (17)

1. Timmermanns PBMWM, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45: 205-251.
2. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A. Angiotensin II-forming pathways in normal and failing human hearts. Circulation Res 1990; 66: 883-890.
3. Hodsman GP, Isles CG, Murray GD, Usherwood TP, Webb DJ, Robertson JIS. Factors related to first dose hypotensive effect of captopril: prediction and treatment. Br Med J 1983; 286: 832-834.
4. Jackson B, Cubela R, Johnston CI. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril in essential hypertension. J Hypertension 1984; 2: 371-377.
5. Osterziel KJ, Karr M, Busch Ch, Dietz R. Comparison of the first-dose effect of captopril and lisinopril in heart failure. Am J Cardiol 1992; 70: 137C-139C.
6. Mufano A, Christen Y, Nussberger J, et al. Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist. Clin Pharmacol Ther 1992; 51: 513-521.
7. Ohtawa M, Takayama F, Saitoh K, Yoshinaga T, Nakashima M. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans. Br J Clin Pharmacol 1993; 35: 290-297.
8. Brunner HR, Christen Y, Mufano A, Lee RJ, Waeber B, Nussberger J. Clinical experience with angiotensin II receptor antagonists. Am J Hypertension 1992; 5: 243S-246S.
9. Gradmann AH, Arcuri KE, Goldberg AI, et al. A randomized, placebo-controlled double-blind study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 1995; 25: 1345-1350.
10. Chan JCN, Critchley JAJH, Lappe JT, et al. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension. J Human Hypertension 1995; 9: 765-771.
11. Soffer BA, Wright JT, Pratt JH, Wiens B, Goldberg AI, Sweet C. Effects of losartan on a background of hydrochlorothiazide in patients with hypertension. Hypertension 1995; 26: 112-117.
12. Webster J. Angiotensin converting enzyme inhibitors in the clinic: first-dose hypotension. J Hypertension 1987; 5: S27-S30.
13. Weber MA, Byyny RL, Pratt JH, et al. Blood pressure effects of the angiotensin II receptor blocker losartan. Arch Intern Med 1995; 155: 405-411.
14. Wong PC, Barnes TB, Chiu AT, et al. Losartan (DUP 753), an orally active angiotensin II receptor antagonist. Cardiovasc Drug Rev 1991; 9: 317-339.
15. Siegl PKS. Discovery of losartan, the first specific non-peptide angiotensin II receptor antagonist. J Hypertension 1993; 11: S19-S22.
16. Mallion JM, Bradsted DC, Makris L, et al. Antihypertensive efficacy and tolerability of once daily losartan potassium compared with captopril in patients with mild to moderate essential hypertension. J Hypertension 1995; 13(suppl 1): S35-S41.
17. Nakashima M, Uematsu T, Kosuge K, Kanamaru M. Pilot study of the uricosuric effect of DUP 753, a new angiotensin II receptor antagonist, in healthy subjects. Eur J Clin Pharmacol 1992; 42: 333-335.